To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene ZNF622TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
236 supporting clones for gene ZNF622 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DB445509 testis .a 1 to 419 1 to 419   tiling clone,   419/419
(100 %)
0 diff
(100 %id)
DB454795 testis .a 1 to 466 1 to 466       466/466
(100 %)
1 diff
(99.8 %id)
AY046059   .a 170 to 1872 1 to 1702 exact     1702/1702
(100 %)
6 diff
(99.7 %id)
BM560250 astrocytoma grade IV, cell line, brain .a 174 to 925 1 to 756       756/1108
(68 %)
16 diff
(98.6 %id)
CR591618 HeLa cells Cot 25-normalized .a 175 to 1860 1 to 1686 exact     1686/1686
(100 %)
0 diff
(100 %id)
BM910554 astrocytoma grade IV, cell line, brain .a 175 to 753 1 to 578       578/1103
(52 %)
45 diff
(96.0 %id)
BM809889 astrocytoma grade IV, cell line, brain .a 175 to 672 1 to 500       500/1256
(39 %)
21 diff
(98.4 %id)
BQ424632 melanotic melanoma, skin .a 176 to 801 1 to 630       630/936
(67 %)
17 diff
(98.2 %id)
BI116159 lung, small cell carcinoma .a 177 to 868 1 to 706       706/708
(99 %)
37 diff
(94.8 %id)
CN366479 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 178 to 766 1 to 589       589/589
(100 %)
1 diff
(99.9 %id)
CR604339 Placenta Cot 25-normalized .a 178 to 1815 1 to 1638 exact     1638/1638
(100 %)
0 diff
(100 %id)
BX395727 Placenta Cot 25-normalized .a 178 to 1036 1 to 857   fully sequenced,   857/857
(100 %)
3 diff
(99.7 %id)
AL564619 brain, fetal liver, Liver, neuroblastoma cells .a 178 to 1074 1 to 896       896/896
(100 %)
6 diff
(99.4 %id)
BM015867 breast, mammary adenocarcinoma, cell line .a 178 to 926 13 to 763       751/867
(86 %)
14 diff
(98.4 %id)
TI_59394229   .a 178 to 926 108 to 858       751/867
(86 %)
14 diff
(98.4 %id)
BX331526 Neuroblastoma Cot 10-normalized .a 179 to 899 1 to 719       719/719
(100 %)
3 diff
(99.6 %id)
BQ070666 brain, neuroblastoma, cell line .a 179 to 933 1 to 754       754/1049
(71 %)
11 diff
(99.0 %id)
BU150632 brain, neuroblastoma, cell line .a 179 to 1101 1 to 925       925/927
(99 %)
23 diff
(97.6 %id)
AV685969 hepatocellular carcinoma .a 180 to 633 1 to 454       454/626
(72 %)
3 diff
(99.6 %id)
BM152862 leukopheresis .a 180 to 672 1 to 493       493/494
(99 %)
2 diff
(99.6 %id)
BG476353 melanotic melanoma, skin .a 181 to 695 1 to 523       523/667
(78 %)
17 diff
(97.5 %id)
BC008752 Skin, melanotic melanoma. .a 182 to 1872 1 to 1691 exact tiling clone, available from MGC, AAA   1691/1691
(100 %)
0 diff
(100 %id)
NM_033414.2   .a 182 to 1872 1 to 1691 exact RefSeq, AAA   1691/1691
(100 %)
0 diff
(100 %id)
BG716348 brain, hypothalamus .a 183 to 795 1 to 607       607/607
(100 %)
19 diff
(96.9 %id)
AL555060 placenta .a 184 to 957 12 to 785   fully sequenced,   774/785
(98 %)
6 diff
(99.3 %id)
BG323222 Kidney, renal cell adenocarcinoma .a 184 to 673 1 to 491       491/986
(49 %)
9 diff
(99.1 %id)
BM921972 pooled brain, lung, testis .a 184 to 1082 14 to 920       907/1027
(88 %)
16 diff
(98.5 %id)
BX416933 placenta .a 185 to 445 1 to 259       259/259
(100 %)
2 diff
(99.3 %id)
DN990273 brain, whole brain .a 185 to 810 8 to 633       626/633
(98 %)
6 diff
(99.1 %id)
BF724659 eye, Iris .a 186 to 494 1 to 309       309/309
(100 %)
0 diff
(100 %id)
BU538604 adenocarcinoma, cell line, breast .a 186 to 1065 1 to 889       889/889
(100 %)
14 diff
(98.5 %id)
BU857013 adenocarcinoma, cell line, breast .a 186 to 1097 1 to 918       918/918
(100 %)
23 diff
(97.5 %id)
BU501191 eye, normal pigmented retinal epithelium .a 189 to 1093 1 to 906       906/910
(99 %)
14 diff
(98.5 %id)
AA324062 brain, cerebellum .a 191 to 386 1 to 197       197/197
(100 %)
2 diff
(99.0 %id)
AA186595 Pancreas .a 191 to 444 1 to 255       255/256
(99 %)
10 diff
(96.1 %id)
BE267460 lung, small cell carcinoma .a 192 to 929 26 to 761       736/977
(75 %)
13 diff
(98.7 %id)
BC010545 Cervix, carcinoma .a 193 to 1872 1 to 1680 exact available from MGC, AAA   1680/1680
(100 %)
0 diff
(100 %id)
CV810100 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 193 to 915 1 to 723       723/723
(100 %)
1 diff
(99.9 %id)
CR626791 T cells (Jurkat cell line) .a 195 to 1758 1 to 1564 exact     1564/1564
(100 %)
0 diff
(100 %id)
AL556982 T cells (Jurkat cell line), T cells from T cell leukemia .a 195 to 1072 1 to 875   fully sequenced,   875/875
(100 %)
3 diff
(99.7 %id)
BY799227 eye .a 195 to 729 1 to 535       535/535
(100 %)
1 diff
(99.9 %id)
CR624583 placenta .a 196 to 1846 1 to 1651 exact     1651/1651
(100 %)
0 diff
(100 %id)
AL542211 placenta .a 196 to 1072 1 to 874   fully sequenced,   874/874
(100 %)
3 diff
(99.7 %id)
BG423246 Kidney, renal cell adenocarcinoma .a 198 to 511 1 to 313       313/313
(100 %)
1 diff
(99.7 %id)
BX425511 neuroblastoma .a 199 to 1259 1 to 1056   fully sequenced,   1056/1056
(100 %)
12 diff
(98.9 %id)
CR599167 neuroblastoma .a 199 to 1871 1 to 1673 exact     1673/1673
(100 %)
0 diff
(100 %id)
BE275770 melanotic melanoma, skin .a 201 to 674 1 to 474       474/474
(100 %)
0 diff
(100 %id)
BE387995 endometrium, adenocarcinoma cell line, uterus .a 201 to 758 1 to 562       562/562
(100 %)
7 diff
(98.8 %id)
BE384978 melanotic melanoma, skin .a 201 to 833 1 to 630       630/644
(97 %)
6 diff
(99.1 %id)
BE407229 choriocarcinoma, placenta .a 201 to 835 1 to 631       631/636
(99 %)
6 diff
(99.1 %id)
BE018152 cervical carcinoma cell line, cervix .a 202 to 691 1 to 490       490/490
(100 %)
1 diff
(99.8 %id)
BM913020 amelanotic melanoma, cell line, skin .a 202 to 926 1 to 725       725/1097
(66 %)
6 diff
(99.5 %id)
DN994763 brain, whole brain .a 202 to 860 8 to 666       659/666
(98 %)
6 diff
(99.1 %id)
BG765531 melanotic melanoma, high MDR (cell line), skin .a 206 to 933 1 to 734       734/758
(96 %)
28 diff
(96.4 %id)
TI_154195400   .a 207 to 1055 51 to 883       833/1012
(82 %)
22 diff
(97.9 %id)
CN366475 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 211 to 671 16 to 477       462/477
(96 %)
6 diff
(98.8 %id)
CN366476 embryonic stem cells, DMSO-treated H9 cellline .a 211 to 973 1 to 763       763/763
(100 %)
5 diff
(99.4 %id)
BI468335 insulinoma, Pancreas .a 211 to 691 7 to 487       481/487
(98 %)
5 diff
(99.0 %id)
BU157278 adenocarcinoma, Pancreas .a 211 to 890 1 to 693       693/998
(69 %)
17 diff
(98.3 %id)
AW249446 lung, small cell carcinoma .a 214 to 454 9 to 249       241/249
(96 %)
6 diff
(97.6 %id)
BM807748 amelanotic melanoma, cell line, skin .a 214 to 872 1 to 659       659/1132
(58 %)
15 diff
(98.7 %id)
CD514154 brain, Pituitary .a 214 to 1065 23 to 881       859/881
(97 %)
19 diff
(97.9 %id)
CR605829 Neuroblastoma Cot 25-normalized .a 216 to 1861 1 to 1646 exact     1646/1646
(100 %)
0 diff
(100 %id)
CR624161 neuroblastoma .a 216 to 1838 1 to 1623 exact     1623/1623
(100 %)
0 diff
(100 %id)
AL516706 brain, neuroblastoma, neuroblastoma cells .a 216 to 926 1 to 708       708/965
(73 %)
17 diff
(98.3 %id)
BX354974 Neuroblastoma Cot 25-normalized .a 216 to 1072 1 to 853   fully sequenced,   853/853
(100 %)
3 diff
(99.7 %id)
CN366477 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 218 to 900 1 to 684       684/684
(100 %)
7 diff
(99.0 %id)
BI521501 pooled pancreas and spleen .a 218 to 921 1 to 727       727/957
(75 %)
46 diff
(95.2 %id)
CX873438 embryonic stem .a 218 to 805 1 to 588       588/588
(100 %)
0 diff
(100 %id)
ES311020 scalp interfollicular dermis, skin .a 220 to 683 1 to 466       466/466
(100 %)
5 diff
(99.0 %id)
BX383866   .a 222 to 1109 1 to 887   fully sequenced,   887/887
(100 %)
6 diff
(99.4 %id)
BG481266 choriocarcinoma, placenta .a 223 to 909 1 to 685       685/685
(100 %)
6 diff
(99.2 %id)
BG774066 choriocarcinoma, placenta .a 223 to 873 1 to 652       652/652
(100 %)
6 diff
(99.1 %id)
BG773673 choriocarcinoma, placenta .a 223 to 628 1 to 404       404/772
(52 %)
11 diff
(98.6 %id)
BG744310 blood, natural killer cells, cell line .a 223 to 867 1 to 644       644/644
(100 %)
2 diff
(99.7 %id)
BQ051792 blood, natural killer cells, cell line .a 225 to 1198 1 to 986       986/1036
(95 %)
39 diff
(96.3 %id)
CR609231 Neuroblastoma Cot 10-normalized .a 228 to 1812 1 to 1585 exact     1585/1585
(100 %)
0 diff
(100 %id)
AL520511 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .a 228 to 1072 1 to 842   fully sequenced,   842/842
(100 %)
3 diff
(99.7 %id)
BE798670 lung, small cell carcinoma .a 228 to 1001 1 to 769       769/882
(87 %)
29 diff
(96.8 %id)
CX756607 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 228 to 960 36 to 768     Submitted on the opposite strand 733/770
(95 %)
7 diff
(99.1 %id)
CX753916 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 231 to 910 1 to 673     Submitted on the opposite strand 673/812
(82 %)
10 diff
(98.8 %id)
BG171124 hypernephroma, cell line, Kidney .a 234 to 887 1 to 645       645/645
(100 %)
14 diff
(97.9 %id)
BE548931 cervical carcinoma cell line, cervix .a 235 to 890 1 to 653       653/653
(100 %)
14 diff
(97.9 %id)
BE264779 lung, small cell carcinoma .a 239 to 716 1 to 478       478/480
(99 %)
2 diff
(99.6 %id)
AA194818 muscle, skeletal muscle .a 243 to 366 1 to 123     Submitted on the opposite strand 123/125
(98 %)
5 diff
(96.0 %id)
AA486215   .a 243 to 472 1 to 228     Submitted on the opposite strand 228/229
(99 %)
7 diff
(97.0 %id)
BX453712 fetal liver, Liver .a 247 to 1164 918 to 1       918/918
(100 %)
21 diff
(97.8 %id)
BE271703 adenocarcinoma cell line, ovary .a 254 to 998 1 to 740       740/923
(80 %)
11 diff
(98.9 %id)
CN366480 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 266 to 831 1 to 567       567/567
(100 %)
1 diff
(99.9 %id)
BF313325 brain, neuroblastoma .a 273 to 998 1 to 710       710/835
(85 %)
37 diff
(95.6 %id)
TI_1948132085   .a 297 to 1124 128 to 948       821/1370
(59 %)
48 diff
(96.5 %id)
TI_1948132086   .a 297 to 1150 120 to 983       864/1160
(74 %)
33 diff
(97.2 %id)
TI_1948132404   .a 297 to 981 123 to 807       685/1369
(50 %)
23 diff
(98.4 %id)
TI_1948132405   .a 297 to 1112 123 to 945       823/1175
(70 %)
37 diff
(96.9 %id)
TI_1948132716   .a 297 to 1084 118 to 915       798/1474
(54 %)
32 diff
(97.9 %id)
TI_1948132717   .a 297 to 1138 119 to 968       850/1183
(71 %)
29 diff
(97.6 %id)
TI_1948133025   .a 297 to 1014 118 to 834       717/1359
(52 %)
21 diff
(98.5 %id)
TI_1948133026   .a 297 to 1106 122 to 937       816/1218
(66 %)
33 diff
(97.3 %id)
BE791299 lung, small cell carcinoma .a 328 to 1116 1 to 783       783/1114
(70 %)
11 diff
(99.1 %id)
BE794037 lung, small cell carcinoma .a 328 to 938 1 to 611       611/611
(100 %)
0 diff
(100 %id)
BG165693 hypernephroma, cell line, Kidney .a 490 to 1191 1 to 689       689/924
(74 %)
15 diff
(98.4 %id)
BF527394 anaplastic oligodendroglioma with 1p/19qloss, brain .a 575 to 1012 366 to 807       782/900
(86 %)
48 diff
(94.7 %id)
BQ327498 kidney_tumor .a 594 to 1179 590 to 4       587/590
(99 %)
4 diff
(99.4 %id)
CB270142 adipose .a 616 to 1159 1 to 544       544/544
(100 %)
0 diff
(100 %id)
CB108210 Liver .a 616 to 998 1 to 383       383/383
(100 %)
0 diff
(100 %id)
BI481265 Native Retinal Pigment Epithelium sheets, retina .a 681 to 1088 5 to 427       434/427
(101 %)
64 diff
(85.1 %id)
TI_1948132718   .a 689 to 1741 1174 to 116       1059/1292
(81 %)
50 diff
(96.2 %id)
BE315441 adenocarcinoma cell line, ovary .a 698 to 819 466 to 590       525/590
(88 %)
35 diff
(94.1 %id)
TI_1948132087   .a 712 to 1733 1158 to 126       1033/1282
(80 %)
38 diff
(97.1 %id)
TI_1948132406   .a 728 to 1741 1138 to 116       1023/1293
(79 %)
65 diff
(95.0 %id)
BG341514 B-cells, primary B-cells from tonsils (cell line) .a 746 to 1351 1 to 608       608/924
(65 %)
7 diff
(99.3 %id)
AW878774 ovary .a 839 to 1213 386 to 13       374/389
(96 %)
0 diff
(100 %id)
BM797693 Ascites, stomach .a 864 to 1223 1 to 360       360/360
(100 %)
5 diff
(98.7 %id)
BM824811 Ascites, stomach .a 876 to 1389 1 to 514       514/514
(100 %)
0 diff
(100 %id)
BF930525 nervous_tumor .a 879 to 1319 1 to 441       441/441
(100 %)
8 diff
(98.2 %id)
BQ068826 brain, neuroblastoma, cell line .a 883 to 1802 1 to 929       929/979
(94 %)
20 diff
(98.0 %id)
AV708572 adrenal gland .a 891 to 1282 1 to 392       392/392
(100 %)
0 diff
(100 %id)
BM701410 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 895 to 1241 1 to 347       347/347
(100 %)
0 diff
(100 %id)
AL577663 placenta .a 900 to 1821 963 to 41   fully sequenced,   923/963
(95 %)
0 diff
(100 %id)
BF924503 nervous_tumor .a 902 to 1326 1 to 425       425/425
(100 %)
1 diff
(99.8 %id)
BF930529 nervous_tumor .a 902 to 1338 1 to 436       436/437
(99 %)
6 diff
(98.7 %id)
BE719974 head_neck .a 903 to 1133 267 to 35       233/270
(86 %)
2 diff
(99.3 %id)
AL564547 brain, fetal liver, Liver, neuroblastoma cells .a 903 to 1841 941 to 1       941/941
(100 %)
3 diff
(99.7 %id)
BE932971 head_neck .a 908 to 1103 206 to 9       198/208
(95 %)
3 diff
(98.6 %id)
BF366334 nervous_tumor .a 917 to 1263 353 to 7       347/353
(98 %)
1 diff
(99.8 %id)
BE925232 amnion_normal .a 918 to 1133 247 to 33       215/254
(84 %)
0 diff
(100 %id)
TI_1948133027   .a 926 to 1732 932 to 124       809/1350
(59 %)
9 diff
(99.4 %id)
AL516705 brain, neuroblastoma, neuroblastoma cells .a 927 to 1825 925 to 14       912/1097
(83 %)
47 diff
(95.8 %id)
TI_1948132719   .a 927 to 1741 934 to 121       814/1255
(64 %)
17 diff
(98.7 %id)
TI_1948133028   .a 929 to 1732 931 to 130       802/1265
(63 %)
28 diff
(97.8 %id)
BE932990 head_neck .a 936 to 1131 3 to 197       195/197
(98 %)
10 diff
(95.0 %id)
BE932989 head_neck .a 937 to 1131 1 to 194       194/194
(100 %)
3 diff
(98.5 %id)
BF755606 colon .a 952 to 1131 24 to 202       179/202
(88 %)
6 diff
(97.1 %id)
TI_227714028   .a 961 to 1864 984 to 99       886/1060
(83 %)
21 diff
(98.1 %id)
BG491856 amelanotic melanoma, cell line, skin .a 967 to 1826 866 to 4       863/867
(99 %)
0 diff
(100 %id)
BM424037 amelanotic melanoma, cell line, skin .a 967 to 1445 1 to 481       484/957
(50 %)
44 diff
(95.5 %id)
BM810137 amelanotic melanoma, cell line, skin .a 968 to 1873 1 to 910       910/1166
(78 %)
19 diff
(98.4 %id)
BX395726 Placenta Cot 25-normalized .a 1006 to 1815 810 to 1   fully sequenced,   810/810
(100 %)
2 diff
(99.8 %id)
TI_154127581   .a 1010 to 1872 953 to 94   AAA   860/1015
(84 %)
12 diff
(98.9 %id)
BF836967 head_neck .a 1012 to 1131 1 to 122       122/122
(100 %)
6 diff
(95.1 %id)
TI_1948132088   .a 1016 to 1733 853 to 131       723/1285
(56 %)
23 diff
(98.3 %id)
AL561887 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .a 1042 to 1807 771 to 6   fully sequenced,   766/771
(99 %)
7 diff
(99.1 %id)
BX354973 Neuroblastoma Cot 25-normalized .a 1042 to 1861 820 to 1   fully sequenced,   820/820
(100 %)
4 diff
(99.6 %id)
AL569309 placenta .a 1042 to 1846 805 to 1   fully sequenced,   805/805
(100 %)
6 diff
(99.3 %id)
AL579095 T cells (Jurkat cell line), T cells from T cell leukemia .a 1042 to 1638 735 to 135   fully sequenced, AAA   601/721
(83 %)
8 diff
(98.9 %id)
AV708897 adrenal gland .a 1048 to 1412 1 to 365       365/365
(100 %)
0 diff
(100 %id)
AA364410 pineal body .a 1067 to 1396 1 to 331       329/331
(99 %)
7 diff
(97.9 %id)
AW953814   .a 1068 to 1608 1 to 541       541/619
(87 %)
10 diff
(98.4 %id)
TI_227713204   .a 1080 to 1872 883 to 98   AAA   786/1007
(78 %)
13 diff
(98.8 %id)
TI_1948132407   .a 1100 to 1741 767 to 124       644/1320
(48 %)
17 diff
(98.8 %id)
BX330965   .a 1102 to 1871 776 to 1   fully sequenced,   776/776
(100 %)
38 diff
(95.2 %id)
AA506325 Prostate .a 1104 to 1559 8 to 462       455/462
(98 %)
7 diff
(98.5 %id)
TI_154111421   .a 1111 to 1872 836 to 87   AAA   750/944
(79 %)
15 diff
(98.5 %id)
TI_227713974   .a 1116 to 1873 870 to 120       751/1093
(68 %)
10 diff
(99.1 %id)
BE183182 head_neck .a 1119 to 1416 25 to 323       299/323
(92 %)
10 diff
(97.0 %id)
BF940944 brain, oligodendroglioma .a 1127 to 1873 747 to 3       745/747
(99 %)
6 diff
(99.2 %id)
BG744881 blood, natural killer cells, cell line .a 1135 to 1827 696 to 3       694/696
(99 %)
0 diff
(100 %id)
CB155996 Liver .a 1147 to 1785 44 to 682       639/682
(93 %)
6 diff
(99.2 %id)
CD367534 Alveolar Macrophage, lung .a 1163 to 1872 726 to 19   AAA   708/713
(99 %)
8 diff
(98.9 %id)
CA448449 Chondrosarcoma, Left Pubic Bone .a 1173 to 1872 711 to 17   AAA   695/695
(100 %)
5 diff
(99.3 %id)
AA630405   .a 1181 to 1843 662 to 1       662/662
(100 %)
3 diff
(99.6 %id)
TI_149299321   .a 1184 to 1872 766 to 79   AAA   688/828
(83 %)
25 diff
(97.0 %id)
TI_227713785   .a 1184 to 1865 782 to 107       676/1009
(66 %)
7 diff
(99.4 %id)
CD364555 Alveolar Macrophage, lung .a 1184 to 1865 696 to 21       676/709
(95 %)
7 diff
(99.1 %id)
CD367976 Alveolar Macrophage, lung .a 1187 to 1872 699 to 17   AAA   683/683
(100 %)
3 diff
(99.6 %id)
BU631084 cell lines, Chondrosarcoma .a 1188 to 1872 700 to 17   AAA   684/684
(100 %)
1 diff
(99.9 %id)
BQ000791 lung, Metastatic Chondrosarcoma .a 1190 to 1872 699 to 17   AAA   683/684
(99 %)
1 diff
(99.9 %id)
CD364712 Alveolar Macrophage, lung .a 1225 to 1872 666 to 19   AAA   648/648
(100 %)
6 diff
(99.1 %id)
BX433834 neuroblastoma .a 1229 to 1871 650 to 1   fully sequenced,   650/650
(100 %)
18 diff
(97.3 %id)
CA417235 Chondrosarcoma Cell line .a 1248 to 1872 641 to 17   AAA   625/625
(100 %)
0 diff
(100 %id)
CD370621 Alveolar Macrophage, lung .a 1248 to 1872 642 to 19   AAA   624/624
(100 %)
2 diff
(99.7 %id)
CD364759 Alveolar Macrophage, lung .a 1248 to 1864 638 to 22       617/638
(96 %)
0 diff
(100 %id)
AW043746 pooled .a 1250 to 1873 631 to 8       624/631
(98 %)
0 diff
(100 %id)
CA430668 cell lines, Chondrosarcoma .a 1253 to 1872 636 to 19   AAA   618/618
(100 %)
3 diff
(99.6 %id)
BI468334 insulinoma, Pancreas .a 1259 to 1843 630 to 45   AAA   586/615
(95 %)
1 diff
(99.9 %id)
AI435077 pooled .a 1274 to 1872 613 to 15   AAA   599/599
(100 %)
8 diff
(98.7 %id)
AA443233.
matches multiple genes
mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 1283 to 1688 1 to 405     also hits gene SPIRE1 405/405
(100 %)
3 diff
(99.3 %id)
AA595483 Prostate, prostate tumor .a 1283 to 1872 589 to 1       589/589
(100 %)
3 diff
(99.5 %id)
BE326929 Kidney .a 1283 to 1872 592 to 1       592/592
(100 %)
5 diff
(99.2 %id)
BE301634 cervical carcinoma cell line, cervix .a 1295 to 1872 589 to 12   AAA   578/578
(100 %)
2 diff
(99.7 %id)
BM995347 Chondrosarcoma, Left Pubic Bone .a 1297 to 1872 592 to 17   AAA   576/576
(100 %)
1 diff
(99.9 %id)
CN366478 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1299 to 1650 1 to 352       352/352
(100 %)
2 diff
(99.5 %id)
BQ000939 lung, Metastatic Chondrosarcoma .a 1301 to 1872 588 to 17   AAA   572/572
(100 %)
0 diff
(100 %id)
BF437635 Prostate .a 1310 to 1872 563 to 1       563/563
(100 %)
0 diff
(100 %id)
CK902655 insulinoma, Pancreas .a 1316 to 1838 522 to 1       522/527
(99 %)
2 diff
(99.7 %id)
BG742804 skin .a 1326 to 2118 1 to 793   tiling clone,   793/795
(99 %)
7 diff
(99.2 %id)
BM674316 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 1339 to 1872 550 to 17   AAA   534/534
(100 %)
0 diff
(100 %id)
BU784467 insulinoma, Pancreas .a 1345 to 1872 543 to 16   AAA   528/533
(99 %)
2 diff
(99.7 %id)
TI_149308730   .a 1348 to 1872 614 to 90   AAA   525/925
(56 %)
15 diff
(98.4 %id)
FN173095 breast carcinoma .a 1356 to 1456 100 to 1     Submitted on the opposite strand 100/100
(100 %)
1 diff
(99.0 %id)
BG026228 Bone, osteosarcoma, cell line .a 1361 to 1873 1 to 513       513/556
(92 %)
1 diff
(99.9 %id)
BU687192 lung .a 1362 to 1872 527 to 17   AAA   511/511
(100 %)
14 diff
(97.3 %id)
AA085476   .a 1371 to 1873 497 to 1     Submitted on the opposite strand 497/552
(90 %)
7 diff
(98.8 %id)
AI753794 bone marrow stroma .a 1378 to 1872 513 to 19   AAA   495/495
(100 %)
0 diff
(100 %id)
BM975670 lung, Primary Lung Cystic Fibrosis EpithelialCells .a 1390 to 1872 499 to 17   AAA   483/483
(100 %)
0 diff
(100 %id)
AI681648 carcinoid, lung .a 1395 to 1872 490 to 14   AAA   477/477
(100 %)
2 diff
(99.6 %id)
AW070786 breast, four pooled high-grade tumors, including twoprimary tumors and two metastatic to ovary .a 1396 to 1872 477 to 1       477/477
(100 %)
0 diff
(100 %id)
BX091404 heart .a 1407 to 1624 1 to 220       220/221
(99 %)
3 diff
(98.7 %id)
AA009890 heart .a 1407 to 1494 1 to 91   fully sequenced,   91/91
(100 %)
0 diff
(100 %id)
CA424539 cell lines, Chondrosarcoma .a 1408 to 1872 481 to 17   AAA   465/465
(100 %)
2 diff
(99.6 %id)
AI086084 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 1409 to 1872 475 to 12   AAA   464/464
(100 %)
0 diff
(100 %id)
AW250055 lung, small cell carcinoma .a 1409 to 1872 474 to 11   AAA   464/464
(100 %)
2 diff
(99.6 %id)
AI280156 pooled .a 1414 to 1873 461 to 2       460/465
(98 %)
12 diff
(97.5 %id)
AI334423 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 1422 to 1872 451 to 1       451/451
(100 %)
0 diff
(100 %id)
CN366481 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1423 to 1867 1 to 445       445/445
(100 %)
0 diff
(100 %id)
AA580262 colon, colon tumor .a 1425 to 1843 419 to 1       419/419
(100 %)
0 diff
(100 %id)
DB520203 testis .a 1431 to 1871 1 to 441     Submitted on the opposite strand 441/442
(99 %)
1 diff
(99.8 %id)
AA009781 heart .a 1433 to 1873 442 to 2   fully sequenced,   441/442
(99 %)
7 diff
(98.5 %id)
AA633547   .a 1433 to 1843 411 to 1       411/411
(100 %)
6 diff
(98.6 %id)
AI476601 pooled .a 1433 to 1873 447 to 7       441/447
(98 %)
4 diff
(99.2 %id)
AA705307 liver and spleen .a 1447 to 1876 429 to 2       428/429
(99 %)
7 diff
(98.4 %id)
AA514520 colon .a 1448 to 1873 427 to 2       426/427
(99 %)
0 diff
(100 %id)
AA743525 germinal center B cell .a 1448 to 1872 459 to 35   AAA   425/425
(100 %)
1 diff
(99.8 %id)
AA928303 pharynx, squamous cell carcinoma .a 1448 to 1843 396 to 1       396/396
(100 %)
1 diff
(99.8 %id)
AA969540 colon, colon tumor .a 1448 to 1843 396 to 1       396/396
(100 %)
7 diff
(98.3 %id)
AI289582 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 1448 to 1873 433 to 8       426/433
(98 %)
0 diff
(100 %id)
AI478351 Kidney .a 1456 to 1872 417 to 1       417/417
(100 %)
0 diff
(100 %id)
DB510501 testis .a 1459 to 1871 1 to 413     Submitted on the opposite strand 413/414
(99 %)
1 diff
(99.8 %id)
BU627856 Bone, Enchondroma cell line .a 1467 to 1872 424 to 19   AAA   406/406
(100 %)
0 diff
(100 %id)
AA688379 normal prostate, Prostate .a 1476 to 1872 395 to 1       395/395
(100 %)
4 diff
(99.0 %id)
AA749226 germinal center B cell .a 1483 to 1872 402 to 13   AAA   390/390
(100 %)
2 diff
(99.5 %id)
AA486316   .a 1488 to 1870 380 to 1     Submitted on the opposite strand 380/380
(100 %)
3 diff
(99.3 %id)
FN106938 breast carcinoma .a 1491 to 1589 102 to 1     Submitted on the opposite strand 102/102
(100 %)
3 diff
(97.1 %id)
AI539514 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 1510 to 1872 374 to 12   AAA   363/363
(100 %)
3 diff
(99.2 %id)
AI591422 brain, tumor, 5 pooled (see description) .a 1544 to 1872 329 to 1       329/329
(100 %)
2 diff
(99.4 %id)
AA443195 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 1553 to 1872 320 to 1       320/321
(99 %)
0 diff
(100 %id)
AA633905 lung .a 1553 to 1843 291 to 1       291/292
(99 %)
0 diff
(100 %id)
AA748490 germinal center B cell .a 1553 to 1872 332 to 13   AAA   320/320
(100 %)
0 diff
(100 %id)
BF059722 pooled germ cell tumors .a 1554 to 1873 328 to 9       320/328
(97 %)
0 diff
(100 %id)
BF062048 pooled germ cell tumors .a 1554 to 1873 328 to 9       320/328
(97 %)
0 diff
(100 %id)
AA534345 colon .a 1567 to 1873 314 to 8       307/314
(97 %)
0 diff
(100 %id)
AW009850 colon .a 1593 to 1872 280 to 1       280/280
(100 %)
0 diff
(100 %id)
AA157957 Pancreas .a 1609 to 1873 273 to 2       272/278
(97 %)
0 diff
(100 %id)
T36237 thyroid gland .a 1645 to 1872 258 to 29   AAA Submitted on the opposite strand 230/230
(100 %)
2 diff
(99.2 %id)
EC453216 Prostate .a 1669 to 1746 20 to 97       78/97
(80 %)
6 diff
(93.9 %id)
AI624462 Kidney, renal cell tumor .a 1698 to 1872 175 to 1       175/175
(100 %)
0 diff
(100 %id)
Z19560 leg muscle, skeletal muscle .a 1716 to 1872 157 to 1       157/157
(100 %)
1 diff
(99.4 %id)
EC444910 Prostate .a 1779 to 1874 14 to 110       97/111
(87 %)
4 diff
(96.4 %id)
EH347803   .a 1799 to 1872 1 to 74   AAA   74/74
(100 %)
0 diff
(100 %id)
D45761 lung .a 1806 to 1873 1 to 69     Submitted on the opposite strand 69/71
(97 %)
3 diff
(95.8 %id)
TI_154135183   .a 2105 to 3031 1000 to 86   tiling clone, AAA   915/981
(93 %)
43 diff
(95.7 %id)
TI_154135003   .a 2186 to 3031 925 to 84   tiling clone, AAA   842/972
(86 %)
17 diff
(98.3 %id)
AI630821 carcinoid, lung .a 2499 to 3030 532 to 1       532/532
(100 %)
0 diff
(100 %id)
AW339804 carcinoid, lung .a 2540 to 3030 491 to 1       491/491
(100 %)
0 diff
(100 %id)
AI827781 pooled .a 2581 to 3031 455 to 5       451/455
(99 %)
0 diff
(100 %id)
AW873364 carcinoid, lung .a 2582 to 3030 449 to 1       449/451
(99 %)
1 diff
(99.8 %id)
AW341816 carcinoid, lung .a 2604 to 3030 432 to 1       432/432
(100 %)
4 diff
(99.1 %id)
AW449382   .a 2659 to 3031 391 to 18   AAA   374/374
(100 %)
6 diff
(98.4 %id)
AV696890 hepatocellular carcinoma Gene ZNF622, variant not shown         Suspected internal deletion, this clone was ignored    
AV728925 hypothalamus Gene ZNF622, variant not shown         Suspected internal deletion, this clone was ignored    
CD048944 embryonic stem cells, WA01, passage 38 Gene ZNF622, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA Expression Tissue Function, regulation, related genes CI